BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 22588543)

  • 1. The role of Nogo-A in axonal plasticity, regrowth and repair.
    Pernet V; Schwab ME
    Cell Tissue Res; 2012 Jul; 349(1):97-104. PubMed ID: 22588543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
    Hunt D; Coffin RS; Anderson PN
    J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system.
    Buchli AD; Schwab ME
    Ann Med; 2005; 37(8):556-67. PubMed ID: 16338758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nogo and axon regeneration.
    Schwab ME
    Curr Opin Neurobiol; 2004 Feb; 14(1):118-24. PubMed ID: 15018947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.
    Giger RJ; Venkatesh K; Chivatakarn O; Raiker SJ; Robak L; Hofer T; Lee H; Rader C
    Restor Neurol Neurosci; 2008; 26(2-3):97-115. PubMed ID: 18820405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nogo: a molecular determinant of axonal growth and regeneration.
    Grandpré T; Strittmatter SM
    Neuroscientist; 2001 Oct; 7(5):377-86. PubMed ID: 11597097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of interleukin-6 to the extracellular inhibitory environment promotes axonal regeneration and functional recovery following spinal cord injury.
    Yang G; Tang WY
    Int J Mol Med; 2017 Feb; 39(2):437-445. PubMed ID: 28075461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration.
    McGee AW; Strittmatter SM
    Trends Neurosci; 2003 Apr; 26(4):193-8. PubMed ID: 12689770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
    Deng Q; Cai W; Li S; Zhang Y; Su B
    Brain Res Bull; 2013 Oct; 99():140-4. PubMed ID: 24184005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Nogo receptor down-regulates expression of neuronal Nogo-A to enhance axonal regeneration.
    Peng X; Zhou Z; Hu J; Fink DJ; Mata M
    J Biol Chem; 2010 Jan; 285(4):2783-95. PubMed ID: 19901030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of Nogo-A by collagen scaffolds impregnated with bone marrow stromal cell treatment after traumatic brain injury promotes axonal regeneration in rats.
    Mahmood A; Wu H; Qu C; Mahmood S; Xiong Y; Kaplan D; Chopp M
    Brain Res; 2014 Jan; 1542():41-8. PubMed ID: 24177046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.
    Guo X; Zahir T; Mothe A; Shoichet MS; Morshead CM; Katayama Y; Tator CH
    Cell Transplant; 2012; 21(6):1177-97. PubMed ID: 22236767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of axonal regeneration in neurodegenerative disease: focus on Nogo.
    Strittmatter SM
    J Mol Neurosci; 2002; 19(1-2):117-21. PubMed ID: 12212768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed anti-nogo-a antibody application after spinal cord injury shows progressive loss of responsiveness.
    Gonzenbach RR; Zoerner B; Schnell L; Weinmann O; Mir AK; Schwab ME
    J Neurotrauma; 2012 Feb; 29(3):567-78. PubMed ID: 21815784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rewiring of the corticospinal tract in the adult rat after unilateral stroke and anti-Nogo-A therapy.
    Lindau NT; Bänninger BJ; Gullo M; Good NA; Bachmann LC; Starkey ML; Schwab ME
    Brain; 2014 Mar; 137(Pt 3):739-56. PubMed ID: 24355710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE; Liu BP; Park JH; Strittmatter SM
    Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
    Zheng B; Atwal J; Ho C; Case L; He XL; Garcia KC; Steward O; Tessier-Lavigne M
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1205-10. PubMed ID: 15647357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
    GrandPré T; Li S; Strittmatter SM
    Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions.
    Mingorance A; Fontana X; Solé M; Burgaya F; Ureña JM; Teng FY; Tang BL; Hunt D; Anderson PN; Bethea JR; Schwab ME; Soriano E; del Río JA
    Mol Cell Neurosci; 2004 May; 26(1):34-49. PubMed ID: 15121177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury.
    Pot C; Simonen M; Weinmann O; Schnell L; Christ F; Stoeckle S; Berger P; Rülicke T; Suter U; Schwab ME
    J Cell Biol; 2002 Oct; 159(1):29-35. PubMed ID: 12379801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.